Medtronic Catalysts: CathWorks Buy, Diabetes Wins!
Medtronic (MDT) saw near‑term share pressure even as the company secured regulatory wins for its MiniMed 780G insulin platform and moved toward acquiring CathWorks, an AI cardiac-imaging firm. Recent analyst upgrades, Medicare coverage, and product clearances create tangible growth catalysts for the diabetes and cardiology franchises.
